NCT05257031View on ClinicalTrials.gov

Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 12, 2022

Primary Completion Date

September 11, 2022

Study Completion Date

June 30, 2023

Conditions

Nutrition TherapyCritical Illness

Interventions

DRUG

SmofKabiven extra Nitrogen

SmofKabiven extra Nitrogen contains amino acids (Aminoven®), glucose, lipids (SMOFlipid®: 30% soybean oil, 30% medium-chain triglycerides, 25% olive oil, 15% fish oil), and electrolytes.

Trial Locations (1)

Unknown

Municipal Clinical Hospital No. 40 of Moscow Healthcare Department, Moscow